Skip to content

MAZE · Maze Therapeutics, Inc.

Healthcare · +0.2% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 6 feeds behind: Insider filings, 5 days, and 5 more · Every feed →

On this page

The market view

Price chart

The interactive MAZE chart (by TradingView) loads here.

Our take

2 rules fired on MAZE

In short: none of these rules has solid or some evidence yet, so they show no clear lean on MAZE.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for MAZE, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on MAZE, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of MAZE. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 24, 2026–Oct 21, 2026 · UTC dates · today is excluded

Insider sales

Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
3
Earlier median
3
Earlier range
2–4
Distinct filers per 28 daysScale: 0–4
Oct 23, 2025Oct 21, 2026
Earlier periodsLatest 28 daysEarlier median 3Limited or missing history

Who appears in the latest period?

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Jun 24, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 3. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 23, 2025–Nov 19, 2025—Unavailable
Nov 20, 2025–Dec 17, 2025—Unavailable
Dec 18, 2025–Jan 14, 2026—Unavailable
Jan 15, 2026–Feb 11, 2026—Unavailable
Feb 12, 2026–Mar 11, 2026—Unavailable
Mar 12, 2026–Apr 8, 2026—Unavailable
Apr 9, 2026–May 6, 2026—Unavailable
May 7, 2026–Jun 3, 2026—Unavailable
Jun 4, 2026–Jul 1, 20260Partial; excluded
Jul 2, 2026–Jul 29, 20260Within stored history
Jul 30, 2026–Aug 26, 20260Within stored history
Aug 27, 2026–Sep 23, 20260Within stored history
Sep 24, 2026–Oct 21, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 3; range: 2–4.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 23, 2025–Nov 19, 2025—Unavailable
Nov 20, 2025–Dec 17, 2025—Unavailable
Dec 18, 2025–Jan 14, 2026—Unavailable
Jan 15, 2026–Feb 11, 2026—Unavailable
Feb 12, 2026–Mar 11, 2026—Unavailable
Mar 12, 2026–Apr 8, 2026—Unavailable
Apr 9, 2026–May 6, 2026—Unavailable
May 7, 2026–Jun 3, 2026—Unavailable
Jun 4, 2026–Jul 1, 20262Partial; excluded
Jul 2, 2026–Jul 29, 20262Within stored history
Jul 30, 2026–Aug 26, 20263Within stored history
Aug 27, 2026–Sep 23, 20264Within stored history
Sep 24, 2026–Oct 21, 2026Latest period3Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 23, 2025–Nov 19, 2025—Unavailable
Nov 20, 2025–Dec 17, 2025—Unavailable
Dec 18, 2025–Jan 14, 2026—Unavailable
Jan 15, 2026–Feb 11, 2026—Unavailable
Feb 12, 2026–Mar 11, 2026—Unavailable
Mar 12, 2026–Apr 8, 2026—Unavailable
Apr 9, 2026–May 6, 2026—Unavailable
May 7, 2026–Jun 3, 2026—Unavailable
Jun 4, 2026–Jul 1, 2026—Unavailable
Jul 2, 2026–Jul 29, 2026—Unavailable
Jul 30, 2026–Aug 26, 2026—Unavailable
Aug 27, 2026–Sep 23, 2026—Unavailable
Sep 24, 2026–Oct 21, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 23, 2025–Nov 19, 2025—Unavailable
Nov 20, 2025–Dec 17, 2025—Unavailable
Dec 18, 2025–Jan 14, 2026—Unavailable
Jan 15, 2026–Feb 11, 2026—Unavailable
Feb 12, 2026–Mar 11, 2026—Unavailable
Mar 12, 2026–Apr 8, 2026—Unavailable
Apr 9, 2026–May 6, 2026—Unavailable
May 7, 2026–Jun 3, 2026—Unavailable
Jun 4, 2026–Jul 1, 2026—Unavailable
Jul 2, 2026–Jul 29, 2026—Unavailable
Jul 30, 2026–Aug 26, 2026—Unavailable
Aug 27, 2026–Sep 23, 2026—Unavailable
Sep 24, 2026–Oct 21, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Owners & lobbying

All 36 records in this snapshot
  1. Filed
  2. Filed
  3. Filed
  4. Disclosed
    Harold Bernstein · Sale

    Transaction dated Oct 1, 2026

  5. Disclosed
    Jason V Coloma · Sale

    Transaction dated Oct 1, 2026

  6. Disclosed
    Jason V Coloma · Sale

    Transaction dated Oct 1, 2026

  7. Disclosed
    Atul Dandekar · Sale

    Transaction dated Sep 29, 2026

  8. Filed
  9. Filed
  10. Disclosed
    Harold Bernstein · Sale

    Transaction dated Sep 4, 2026

  11. Disclosed
    Atul Dandekar · Sale

    Transaction dated Sep 2, 2026

  12. Disclosed
    Atul Dandekar · Sale

    Transaction dated Sep 2, 2026

  13. Disclosed
    Atul Dandekar · Sale

    Transaction dated Sep 3, 2026

  14. Disclosed
    Atul Dandekar · Sale

    Transaction dated Sep 3, 2026

  15. Disclosed
    Harold Bernstein · Sale

    Transaction dated Sep 2, 2026

  16. Disclosed
    Harold Bernstein · Sale

    Transaction dated Sep 3, 2026

  17. Disclosed
    Harold Bernstein · Sale

    Transaction dated Sep 3, 2026

  18. Disclosed
    Harold Bernstein · Sale

    Transaction dated Sep 2, 2026

  19. Disclosed
    Jason V Coloma · Sale

    Transaction dated Sep 3, 2026

  20. Disclosed
    Jason V Coloma · Sale

    Transaction dated Sep 3, 2026

  21. Disclosed
    Jason V Coloma · Sale

    Transaction dated Sep 2, 2026

  22. Disclosed
    Jason V Coloma · Sale

    Transaction dated Sep 2, 2026

  23. Filed
  24. Disclosed
    Phillips Courtney · Sale

    Transaction dated Sep 2, 2026

  25. Disclosed
    Phillips Courtney · Sale

    Transaction dated Sep 3, 2026

  26. Disclosed
    Phillips Courtney · Sale

    Transaction dated Sep 3, 2026

  27. Disclosed
    Phillips Courtney · Sale

    Transaction dated Sep 2, 2026

  28. Disclosed
    Harold Bernstein · Sale

    Transaction dated Sep 1, 2026

  29. Disclosed
    Jason V Coloma · Sale

    Transaction dated Sep 1, 2026

  30. Disclosed
    Jason V Coloma · Sale

    Transaction dated Sep 1, 2026

  31. Filed
  32. Filed
  33. Disclosed
    Atul Dandekar · Sale

    Transaction dated Aug 28, 2026

  34. Filed
  35. Filed
  36. Filed

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on MAZE disclosed in the last 90 days.

See every Congress trade on MAZE →

Company insiders

0 buys · 14 sells (32 filed lots) · $6.1M sold

  1. ▼ SELLHarold Bernstein President, R&D & CMOMAZE Maze Therapeutics, Inc.$435Kdisclosed Oct 2 · filed 1 day after the trade
  2. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$70.1Kdisclosed Oct 2 · filed 1 day after the trade
  3. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$862Kdisclosed Oct 2 · filed 1 day after the trade
  4. ▼ SELLAtul Dandekar CsboMAZE Maze Therapeutics, Inc.$203Kdisclosed Oct 1 · filed 2 days after the trade
  5. ▼ SELLHarold Bernstein President, R&D & CMOMAZE Maze Therapeutics, Inc.$255Kdisclosed Sep 8 · filed 4 days after the trade
  6. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$3.3Kdisclosed Sep 4 · filed 1 day after the trade
  7. ▼ SELLPhillips Courtney GC and Corp. SecretaryMAZE Maze Therapeutics, Inc.$6.6Kdisclosed Sep 4 · filed 2 days after the trade
  8. ▼ SELLPhillips Courtney GC and Corp. SecretaryMAZE Maze Therapeutics, Inc.$567disclosed Sep 4 · filed 1 day after the trade
  9. ▼ SELLHarold Bernstein President, R&D & CMOMAZE Maze Therapeutics, Inc.$17Kdisclosed Sep 4 · filed 2 days after the trade
  10. ▼ SELLPhillips Courtney GC and Corp. SecretaryMAZE Maze Therapeutics, Inc.$51.8Kdisclosed Sep 4 · filed 1 day after the trade
See every insider trade on MAZE →

Big holders (Schedule 13D / 13G): 1 filing in the last 90 days · newest: BlackRock, Inc. (13G), Jul 29, 2026 ↗

Filings & events

Company filings (8-K) 31

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Directors or officers joined, left or got new pay · item 5.025
  • Quarterly or yearly results · item 2.025
  • Signed a major agreement · item 1.013
  • Shared information with investors · item 7.013
  • Sold shares privately · item 3.022
  • Shareholder vote results · item 5.071

Filing red flags 2

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Planned insider sales (Form 144) 24

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

10 in the last 90 days · 24 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 11

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 0 filings
  • 13G, just holds: 11 filings

Filed most: Foresite Capital Fund IV, L.P. (2) · BlackRock, Inc. (1) · Paradigm Biocapital Advisors LP (1) · ARCH Venture Fund X, L.P. (1)

Biggest named funds (13F)

The largest MAZE holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on MAZE

  1. ▼ SELLHarold Bernstein President, R&D & CMOMAZE Maze Therapeutics, Inc.$435Kdisclosed Oct 2 · filed 1 day after the trade
  2. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$70.1Kdisclosed Oct 2 · filed 1 day after the trade
  3. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$862Kdisclosed Oct 2 · filed 1 day after the trade
  4. ▼ SELLAtul Dandekar CsboMAZE Maze Therapeutics, Inc.$203Kdisclosed Oct 1 · filed 2 days after the trade
  5. ▼ SELLHarold Bernstein President, R&D & CMOMAZE Maze Therapeutics, Inc.$255Kdisclosed Sep 8 · filed 4 days after the trade
  6. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$3.3Kdisclosed Sep 4 · filed 1 day after the trade
  7. ▼ SELLPhillips Courtney GC and Corp. SecretaryMAZE Maze Therapeutics, Inc.$6.6Kdisclosed Sep 4 · filed 2 days after the trade
  8. ▼ SELLPhillips Courtney GC and Corp. SecretaryMAZE Maze Therapeutics, Inc.$567disclosed Sep 4 · filed 1 day after the trade
  9. ▼ SELLHarold Bernstein President, R&D & CMOMAZE Maze Therapeutics, Inc.$17Kdisclosed Sep 4 · filed 2 days after the trade
  10. ▼ SELLPhillips Courtney GC and Corp. SecretaryMAZE Maze Therapeutics, Inc.$51.8Kdisclosed Sep 4 · filed 1 day after the trade
  11. ▼ SELLPhillips Courtney GC and Corp. SecretaryMAZE Maze Therapeutics, Inc.$45.8Kdisclosed Sep 4 · filed 2 days after the trade
  12. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$293Kdisclosed Sep 4 · filed 1 day after the trade
  13. ▼ SELLHarold Bernstein President, R&D & CMOMAZE Maze Therapeutics, Inc.$1.5Kdisclosed Sep 4 · filed 1 day after the trade
  14. ▼ SELLAtul Dandekar CsboMAZE Maze Therapeutics, Inc.$73.9Kdisclosed Sep 4 · filed 2 days after the trade
  15. ▼ SELLAtul Dandekar CsboMAZE Maze Therapeutics, Inc.$10.6Kdisclosed Sep 4 · filed 2 days after the trade
  16. ▼ SELLAtul Dandekar CsboMAZE Maze Therapeutics, Inc.$929disclosed Sep 4 · filed 1 day after the trade
  17. ▼ SELLAtul Dandekar CsboMAZE Maze Therapeutics, Inc.$83.4Kdisclosed Sep 4 · filed 1 day after the trade
  18. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$37.3Kdisclosed Sep 4 · filed 2 days after the trade
  19. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$260Kdisclosed Sep 4 · filed 2 days after the trade
  20. ▼ SELLHarold Bernstein President, R&D & CMOMAZE Maze Therapeutics, Inc.$133Kdisclosed Sep 4 · filed 1 day after the trade
  21. ▼ SELLHarold Bernstein President, R&D & CMOMAZE Maze Therapeutics, Inc.$118Kdisclosed Sep 4 · filed 2 days after the trade
  22. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$839Kdisclosed Sep 3 · filed 2 days after the trade
  23. ▼ SELLJason V Coloma Chief Executive OfficerMAZE Maze Therapeutics, Inc.$68.2Kdisclosed Sep 3 · filed 2 days after the trade
  24. ▼ SELLHarold Bernstein President, R&D & CMOMAZE Maze Therapeutics, Inc.$426Kdisclosed Sep 3 · filed 2 days after the trade
  25. ▼ SELLAtul Dandekar CsboMAZE Maze Therapeutics, Inc.$207Kdisclosed Aug 31 · filed 3 days after the trade
See all 41 trades on MAZE →
People & votes

Which members of Congress traded MAZE, sponsored bills that touch it and voted on them — opens here.